{
  "meta": {
    "title": "214_Medicine_Aiims_2020_May_And_Nov_Ini-Cet",
    "url": "https://brainandscalpel.vercel.app/214-medicine-aiims-2020-may-and-nov-ini-cet-bb63b939.html",
    "scrapedAt": "2025-11-30T12:56:59.648Z"
  },
  "questions": [
    {
      "text": "Which of the following is the drug of choice for hairy cell leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "Rituximab"
        },
        {
          "id": 2,
          "text": "Vemurafenib"
        },
        {
          "id": 3,
          "text": "Cladribine"
        },
        {
          "id": 4,
          "text": "Interferon-alpha"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cladribine</strong> is the drug of choice in <strong>hairy cell leukemia</strong>.</p>\n<p>Cladribine is a <strong>purine analogue</strong> with potent and curative activity against hairy cell leukemia. </p>\n<p>Other treatment options for hairy cell leukemia include <strong>deoxycoformycin</strong>, <strong>interferon-alpha,</strong> and <strong>splenectomy</strong>. Chemotherapy-refractory patients are treated with <strong>vemurafenib</strong>, a BRAF kinase inhibitor. The addition of <strong>rituximab</strong> results in more durable remissions.</p>\n<p>Cladribine is also used to treat CLL, low-grade lymphomas, Langerhans cell histiocytosis, cutaneous T-cell lymphomas, and Waldenstr&ouml;m macroglobulinemia.</p>\n<p>The major dose-limiting toxicity of cladribine is <strong>myelosuppression</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4654",
      "difficulty": "medium"
    },
    {
      "text": "An intubated patient in the ICU had a chest X-ray taken to evaluate for fever spikes over the last 24-48 hours. The radiograph is shown below. What is the next best step in the management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Suction the ET tube"
        },
        {
          "id": 2,
          "text": "Chest physiotherapy twice daily"
        },
        {
          "id": 3,
          "text": "Start antibiotics and send samples for culture"
        },
        {
          "id": 4,
          "text": "Ultrasound-guided aspiration"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical history of an intubated ICU patient and the X-ray features point toward a diagnosis of <strong>pleural effusion.</strong> <strong>Ultrasound-guided aspiration</strong> is the next step in the management of the patient. <strong>Antibiotics</strong> should be started once the pleural tap has been done and infective etiology is suspected.</p>\n<p><strong>Options A and B:</strong> ET tube suctioning and chest physiotherapy are done to remove thick secretions out of the upper and lower respiratory tract. It wouldn't help in removing the fluid of a pleural effusion.</p>\n<p>Pleural effusion is a <strong>common</strong> finding in the <strong>ICU</strong> setting and in <strong>intubated</strong> patients. Many factors contribute to the impairment of pleural fluid turnover in such cases as prolonged recumbency, ventilator-produced positive pressure, and reduced plasma oncotic pressure.</p>\n<p>The diagnosis of pleural effusion may be made by clinical examination (<strong>dull note on percussion)</strong> or by <strong>imaging</strong>. A p<strong>leural tap</strong> for confirmation of diagnosis and to relieve breathing difficulty is now done under ultrasound guidance. </p>\n<p>The <strong>CXR features</strong> of pleural effusion include:</p>\n<ul>\n<li aria-level=\"1\"><strong>Obliteration of costophrenic angle</strong> on the side of pleural effusion</li>\n<li aria-level=\"1\">Air-fluid interface <strong>(meniscus sign)</strong></li>\n<li aria-level=\"1\">Large effusions show: Complete opacification of the lung, mediastinal shift, and tracheal deviation away from the effusion</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/13dd0f1ab9d149ba9c46dd72848559ebx488x422.PNG\" alt=\"Explanation Image\"><p>Differential diagnosis in an intubated patient with opacities on CXR might be pneumonitis secondary to gastric acid or food aspiration. But the X-ray would show patchy infiltration unlike the homogenous density seen in pleural effusion.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/eb36c4e28e1b4be1893c1244b5398713.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4644",
      "difficulty": "medium"
    },
    {
      "text": "Following is a graphic representation of a patient admitted to the medicine ward with fever. What could be the possible diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Cerebral malaria"
        },
        {
          "id": 2,
          "text": "Brucellosis"
        },
        {
          "id": 3,
          "text": "Leptospirosis"
        },
        {
          "id": 4,
          "text": "Typhoid"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given graphical representation of a <strong>biphasic illness</strong> (acute and convalescent phases) and relevant investigations at <strong>different stages</strong> of the disease is consistent with a diagnosis of <strong>leptospirosis.&nbsp;</strong></p>\n<p><strong>Malaria (Option A)</strong> is commonly diagnosed by demonstrating malarial parasites in a peripheral blood smear and not in CSF or urine.</p>\n<p><strong>Brucellosis (Option B)</strong> follows a characteristic pattern of undulating fever.</p>\n<p>The mean incubation period in <strong>typhoid (Option D)</strong> usually ranges from 10 to 14 days and diagnosed based on examination of blood or stool.</p>\n<p><strong>Leptospirosis</strong> is a <strong>zoonotic</strong> disease caused by<strong> gram-negative Leptospira</strong> bacteria (especially L. interrogans). <strong>Direct transmission</strong> to humans occurs when broken skin and mucous membranes come into contact with the urine of infected reservoir hosts such as rodents.&nbsp;</p>\n<p>Illness is classically <strong>biphasic</strong> after an incubation period of up to <strong>1 month,</strong> though the distinction between the first and second phases is not always clear.</p>\n<ul>\n<li aria-level=\"1\">Acute leptospiremic phase-organism can be cultured from blood (within 1 week of onset of symptoms)</li>\n<li aria-level=\"1\">Resolving immune phase-organism can be cultured from urine (after 1 week)</li>\n</ul>\n<p>Most cases are characterized by <strong>non-specific</strong> symptoms (e.g fever, headache, myalgia and conjunctival suffusion) and resolve <strong>spontaneously</strong> within a week but a few may progress to a severe form known as<strong> Weil's disease</strong> which typically presents with a triad of <strong>hemorrhage, jaundice, and acute kidney injury.</strong></p>\n<p>Diagnosis includes:</p>\n<ul>\n<li aria-level=\"1\">Dark-field microscopy of urine or blood samples</li>\n<li aria-level=\"1\"><strong>Serological tests</strong></li>\n</ul>\n<ul>\n<ul>\n<li aria-level=\"1\">Four-fold rise in the level of IgM titers within one month of the onset of symptoms</li>\n<li aria-level=\"1\">Microscopic agglutination test (MAT)</li>\n</ul>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<ul>\n<li>PCR</li>\n<li>Culture on EMJH or Fletchers media</li>\n</ul>\n<p><strong>Treatment:</strong></p>\n<ul>\n<li><strong>Mild disease:</strong> Oral doxycycline or azithromycin or ampicillin/ amoxicillin&nbsp;</li>\n<li><strong>Severe disease:</strong> IV penicillin&nbsp;</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a62a38d9ce53455c9f0c99df90613bf3.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4583",
      "difficulty": "medium"
    },
    {
      "text": "The laboratory investigations of a 65 year old woman revealed a hemoglobin level of 5.4 g/dl, creatinine level of 6 mg/dl, calcium level of 12 mg/dl, potassium level of 4.4 mmol/L. Her urine output in the last 24 hours was 50 ml. Bone marrow aspiration revealed more than 60% of plasma cells. What would be the next appropriate line of management for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Urgent consultation for dialysis"
        },
        {
          "id": 2,
          "text": "Lenalidomide + Bortezomib + Dexamethasone"
        },
        {
          "id": 3,
          "text": "Dexamethasone + fluids"
        },
        {
          "id": 4,
          "text": "Chemotherapy followed by autologous stem cell transplantation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario shows a patient with a bone marrow finding of <strong>plasma cells &gt;60%</strong> which points to a diagnosis of <strong>multiple myeloma.&nbsp; </strong></p>\n<p><strong>Anemia</strong> (Hb- 5.4 g/dl), <strong>hypercalcemia</strong> (serum calcium-12 mg/dl) and <strong>acute kidney injury</strong> (creatinine-6 mg/dl, reduced urine output) are myeloma-defining events suggesting end-organ damage.</p>\n<p>The most appropriate <strong>next step</strong> in managing this patient would be to administer <strong>fluids</strong> to treat the acute kidney injury and hypercalcemia (hypercalcemia is the most common cause of renal failure in multiple myeloma), and prevent further renal impairment. Therefore, among the given options, <strong>dexamethasone and fuids</strong> would be the best answer.</p>\n<p>Multiple myeloma is a <strong>malignant plasma cell dyscrasia</strong> and its diagnosis requires bone marrow biopsy finding of <strong>&ge; 10% clonal bone marrow plasma cells,</strong> a <strong>serum/urine M component,</strong> and at least <strong>one</strong> of the <strong>myeloma-defining events</strong> (hypercalcemia, renal insufficiency, anemia and bone lesions).</p>\n<p><strong>Dialysis (Option A)</strong> is indicated in the following conditions:</p>\n<ul>\n<li aria-level=\"1\">Pulmonary edema not responding to diuretics</li>\n<li aria-level=\"1\">Uremic pericarditis, uremic encephalopathy or uremic syndrome</li>\n<li aria-level=\"1\">Metabolic acidosis not responding to treatment</li>\n<li aria-level=\"1\">Hyperkalemia</li>\n</ul>\n<p><strong>Lenalidomide + Bortezomib + Dexamethasone (Option B)</strong> is the preferred treatment in multiple myeloma and can be initiated after initial management of acute kidney injury.</p>\n<p><strong>Chemotherapy</strong> followed by <strong>autologous stem cell transplantation (Option D)</strong> in transplant-eligible patients prolongs overall survival in multiple myeloma patients.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/56f896aa6c2b4c449e446165261ce012x458x918.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4576",
      "difficulty": "hard"
    },
    {
      "text": "A diabetic nephropathy patient is an ideal candidate for renal graft transplant. Which of the following statements is true?",
      "choices": [
        {
          "id": 1,
          "text": "The survival rate of graft is 95% in the first year"
        },
        {
          "id": 2,
          "text": "The transplantation is cost effective after the second transplant year"
        },
        {
          "id": 3,
          "text": "The life expectancy is doubled in a diabetic patient with renal transplant"
        },
        {
          "id": 4,
          "text": "The treatment of chronic rejection has improved over the last 10 years"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Transplantation becomes <strong>cost-effective</strong> after the <strong>second transplant year</strong> in a patient with <strong>diabetic nephropathy,</strong> provided there is <strong>no chronic rejection.</strong></p>\n<p>The cost of transplantation after the second year becomes lesser compared to thrice-weekly dialysis.</p>\n<p><strong>Other options:</strong></p>\n<p><strong>Options A:</strong> Graft survival in the first year is not 95%. It is around 80%&nbsp;</p>\n<p><strong>Option C:</strong> The life expectancy is not doubled in a patient with diabetic nephropathy post-transplantation</p>\n<p>Option D: As chronic rejection is due to so many variables, the treatment is very difficult. Risk factors that predispose a recipient to long-term graft rejection include HLA-mismatching, acute episodes of graft rejection, mismatch in donor-recipient age, and smoking. Better treatment options are still under research.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4573",
      "difficulty": "hard"
    },
    {
      "text": "A diabetic patient enters the OPD and greets you with a namaste. As the doctor, you notice a deformity in his hand which is shown in the image below. Based on your observation, what is the likely cause of this deformity?",
      "choices": [
        {
          "id": 1,
          "text": "Flexor tenosynovitis"
        },
        {
          "id": 2,
          "text": "Cheiroarthropathy"
        },
        {
          "id": 3,
          "text": "Dupuytrens contracture"
        },
        {
          "id": 4,
          "text": "Ankyloses"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The image shows a <strong>positive namaste</strong> or <strong>prayer sign</strong> where the patient is unable to touch the palmar aspects of both hands and fingers together which is suggestive of <strong>diabetic cheiroarthropathy</strong>.</p>\n<p><strong>Diabetic cheiroarthropathy</strong> also known as <strong>diabetic stiff hand syndrome</strong> is a cutaneous condition characterized by waxy, thickened skin and <strong>limited joint mobility of the </strong>hands and fingers leading to <strong>flexion contractures</strong> (namaste or prayer sign). This occurs due to the non-enzymatic glycosylation of collagen. It is seen in both <strong>diabetes type 1 and type 2</strong>. Its prevalence increases with age and poor glycemic control.</p>\n<p>Other options:</p>\n<p>Option A: Flexor tenosynovitis refers to inflammation of the sheath surrounding the flexor tendons in the hand. <strong>Infectious flexor tenosynovitis</strong> is associated with the <strong>Kanavel&rsquo;s signs</strong> which include:</p>\n<ul>\n<li>Fusiform swelling along the affected finger</li>\n<li>Tenderness with palpation along the tendon sheath</li>\n<li>Flexed posture of the affected finger</li>\n<li>Pain with passive extension</li>\n</ul>\n<p>Option C: Dupuytren's contracture is a <strong>fibroproliferative disorder</strong> affecting the <strong>palmar aponeurosis</strong> of mainly the <strong>4th and 5th fingers</strong>. Skin puckering proximal to the flexor crease is the earliest sign, followed by the development of nodules and cords in the palmar fascia, leading to flexion contractures at the MCP and PIP joints as the disease progresses.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7ebf66ac726e4bf1ae40d287b9585d36x720x464.JPEG\" alt=\"Explanation Image\"><p>Option D: Ankylosis refers to the <strong>fusion of a joint</strong>, resulting in limited or no movement. It can occur due to various causes such as rheumatoid arthritis, osteoarthritis, trauma, or infection.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a27cb0e287bb413e822d26e645f25c43.png"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4536",
      "difficulty": "medium"
    },
    {
      "text": "Dialysis will prevent all except?",
      "choices": [
        {
          "id": 1,
          "text": "Seizures"
        },
        {
          "id": 2,
          "text": "Peripheral neuropathy"
        },
        {
          "id": 3,
          "text": "Metabolic acidosis"
        },
        {
          "id": 4,
          "text": "Uremic pericarditis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Dialysis</strong> does not prevent peripheral neuropathy. Complications like <strong>seizures, metabolic acidosis,</strong> and <strong>uremic pericarditis</strong> can be prevented by dialysis.</p>\n<p><strong>Peripheral neuropathy</strong> is postulated to be caused due to <strong>middle molecules (50-200kDa).</strong> Conventionally used dialysis membranes have pore sizes that prevent larger particles (such as middle molecules) from passing through them. </p>\n<p>Suggested methods for the removal of middle molecules include:</p>\n<ul>\n<li><strong>High flux dialysis</strong></li>\n<li>Protein adsorptive membranes&nbsp;</li>\n<li>High-cutoff membranes</li>\n</ul>\n<p>Aggressive removal of middle molecules or larger low-molecular-weight proteins (LMWPs) has been a growing concern since it causes <strong>massive albumin leakage</strong>.</p>\n<p><strong>&beta;2-microglobulin</strong> (B2M),<strong>&alpha;1-microglobulin</strong> (A1M) and albumin leakage during a dialysis session are useful parameters for assessing middle-molecule removal.</p>\n<p><strong>Renal transplantation</strong> is the best treatment option available for peripheral neuropathy in diabetes.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4431",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a treatment option in Guillain Barre syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Steroids"
        },
        {
          "id": 2,
          "text": "Plasmapheresis"
        },
        {
          "id": 3,
          "text": "IVIG"
        },
        {
          "id": 4,
          "text": "Ventilator support"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Steroids</strong> are <strong>not used</strong> in the treatment of Guillain Barre syndrome (GBS).</p>\n<p>GBS is an acute, fulminant, <strong>ascending polyradiculoneuropathy</strong> that is autoimmune in nature. GBS is caused when immune response/antibodies against external antigens like infections, vaccines, etc target similar proteins present in the person's nervous tissue. Hence the preferred treatment is to neutralize these autoantibodies using<strong> IVIg (I.V. immunoglobulins) or plasmapheresis&nbsp;(Option B and Option C).</strong></p>\n<p>GBS manifests as rapidly evolving<strong> ascending areflexic motor paralysis</strong> with or without sensory disturbance. GBS paralysis can also affect the muscles of <strong>respiration</strong>, possibly leading to death due to <strong>respiratory failure.</strong> In such cases, ventilatory support<strong> (Option D)</strong> is needed.</p>\n<p>&nbsp;Note:&nbsp;Steroid therapy is used in <strong>Chronic inflammatory demyelinating polyneuropathy</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4416",
      "difficulty": "medium"
    },
    {
      "text": "Which part of the internal capsule is affected in hemiplegia due to ischaemic stroke?",
      "choices": [
        {
          "id": 1,
          "text": "Retrolentiform"
        },
        {
          "id": 2,
          "text": "Sublentiform"
        },
        {
          "id": 3,
          "text": "Anterior limb"
        },
        {
          "id": 4,
          "text": "Posterior limb"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>posterior limb of the internal capsule</strong> is affected in <strong>hemiplegia</strong> due to ischaemic stroke.</p>\n<p>Motor fibers (cortico-spinal tract) supplying the extremities are present in the posterior limb, hence a lesion in this region may cause hemiplegia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b1deb43b58fa43c896f888afc0c31c4dx1280x1625.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Internal capsule parts and fibers</h3><table>\n<tbody>\n<tr>\n<td>Part of Internal<br />capsule</td>\n<td>Motor<br />fibers/descending tracts</td>\n<td>Sensory fibers/<br />ascending tracts</td>\n</tr>\n<tr>\n<td>Anterior limb</td>\n<td>\n<ul>\n<li>Frontopontine</li>\n</ul>\n</td>\n<td>Anterior thalamic radiation</td>\n</tr>\n<tr>\n<td><strong>Genu</strong></td>\n<td>\n<ul>\n<li>Corticonuclear</li>\n<li>Corticospinal</li>\n</ul>\n</td>\n<td>Superior thalamic<br />radiation</td>\n</tr>\n<tr>\n<td><strong>Posterior limb</strong></td>\n<td>\n<ul>\n<li><strong>Corticospinal</strong></li>\n<li>Corticorubral</li>\n<li>Frontopontine</li>\n</ul>\n</td>\n<td>Superior thalamic<br />radiation</td>\n</tr>\n<tr>\n<td>Retrolentiform part</td>\n<td>\n<ul>\n<li>Parietopontine</li>\n<li>Occipitopontine</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>Occipitotectal</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Posterior thalamic<br />radiation</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>Optic<br />radiation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Sublentiform part</td>\n<td>\n<ul>\n<li>Temporopontine</li>\n<li>Parietopontine</li>\n</ul>\n</td>\n<td>Auditory radiation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Blood supply of internal capsule.</h3><div>&nbsp;</div>\n<table><colgroup><col /></colgroup>\n<tbody>\n<tr>\n<td>\n<div>Blood supply of internal capsule.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anterior limb&nbsp;</p>\n<ul>\n<li>Recurrent artery of Heubner</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div>Genu&nbsp;</div>\n<ul>\n<li>Recurrent artery of Heubner</li>\n<li>Charcot's artery (lenticulostriate artery or artery of cerebral hemorrrahge)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div>Posterior limb</div>\n<ul>\n<li>Charcot's artery (branch of Middle cerebral artery)</li>\n<li>Anterior choroidal artery ( branch of internal carotid artery)</li>\n<li>Posterolateral branches of posterior cerebral artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div>Sublentiform part</div>\n<ul>\n<li>Anterior choroidal artery</li>\n<li>Posterior cerebral artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div>Retrolentiform part</div>\n<ul>\n<li>Posterolateral branches of posterior cerebral artery</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4415",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is false about mycoplasma pneumonia?",
      "choices": [
        {
          "id": 1,
          "text": "Responds well to amoxiclav"
        },
        {
          "id": 2,
          "text": "Antibody are useful in diagnosis"
        },
        {
          "id": 3,
          "text": "Chest X-ray shows bilateral infiltrates"
        },
        {
          "id": 4,
          "text": "Can be cultured in a cell-free medium"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Mycoplasma</strong> does <strong>not</strong> respond to amoxicillin-clavulanate (amoxiclav).</p>\n<p>Mycoplasma is a bacteria that <strong>lacks a cell wall.</strong> Since<strong> beta-lactam antibiotics</strong> (amoxiclav) act on the <strong>cell wall</strong> of the bacterium, they can not be used in the treatment of mycoplasma infection.&nbsp;</p>\n<p>The diagnosis of mycoplasma pneumonia (also known as walking pneumonia/ primary atypical pneumonia) can be established by:</p>\n<ul>\n<li aria-level=\"1\"><strong>PCR detection</strong> of M. pneumoniae in respiratory secretions</li>\n<li aria-level=\"1\">Serological tests for <strong>IgM and IgG</strong> antibodies to M.pneumoniae in paired serum samples</li>\n<li aria-level=\"1\"><strong>Culture:</strong>&nbsp;Mycoplasma can be cultured on PPLO agar, a cell-free medium, and shows a typical <strong>fried egg appearance</strong></li>\n</ul>\n<p>Chest X-ray usually shows <strong>B/L peribronchial and perivascular interstitial infiltrates</strong></p>\n<p>Treatment options for mycoplasma pneumonia&nbsp; include:</p>\n<ul>\n<li aria-level=\"1\">&nbsp;Macrolides (e.g. azithromycin)</li>\n<li aria-level=\"1\">&nbsp;Tetracyclines (e.g. doxycycline)</li>\n<li aria-level=\"1\">&nbsp;Respiratory fluoroquinolones. (e.g. levofloxacin)</li>\n</ul>\n<p><strong>Azithromycin</strong> is the <strong>drug of choice</strong> for the management of mycoplasma pneumonia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4413",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old chronic smoker presented with mild recurrent hemoptysis without fever or weight loss. The chest X-ray appears normal and the sputum is negative for AFB. Which of the following is the next best diagnostic investigation?",
      "choices": [
        {
          "id": 1,
          "text": "MRI"
        },
        {
          "id": 2,
          "text": "CT"
        },
        {
          "id": 3,
          "text": "Fiberoptic bronchoscopy"
        },
        {
          "id": 4,
          "text": "Bronchography"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p id=\"idm139695396496384\" class=\"p p-first\">In this case, considering the patient's age of <strong>50 years</strong>, history of <strong>chronic smoking,</strong> and recurrent <strong>hemoptysis</strong>, all of which raise suspicion for <strong>lung malignancy,</strong> the next best diagnostic investigation would be a <strong>CT scan.&nbsp;</strong></p>\n<p class=\"p p-first\">Any patient presenting with recurrent hemoptysis requires chest imaging. The initial imaging modality is a <strong>plain radiograph.</strong> However, patients with&nbsp;<strong>risk factors</strong> for<strong> malignancy</strong> need further evaluation&nbsp;with a<strong> CT scan</strong>.&nbsp;</p>\n<p class=\"p p-first\">CT can identify masses, bronchiectasis, and parenchymal lesions. Further management depends on the CT findings. <strong>Fiberoptic bronchoscopy,</strong> which is an invasive procedure, is done after a mass is seen on a CT scan to enable sample collection for <strong>biopsy</strong>. Also, bronchoscopy has an overall <strong>lower sensitivity</strong> than MDCT in detecting the underlying causes of bleeding.</p>\n<p>Other options:</p>\n<p><strong>Option A:</strong> While <strong>MRI</strong> can be valuable in certain situations, such as evaluating the mediastinum or vascular structures, a chest CT scan is generally the preferred initial diagnostic investigation for assessing lung pathology, especially in cases of hemoptysis. </p>\n<p><strong>Option D:</strong> <strong>Bronchography</strong> is visualizing the tracheobronchial tree on plain radiography by instilling contrast material via the bronchus. It has been replaced by advancements in CT scans.</p>\n<p><strong>Risk factors</strong> for the development of lung cancer:</p>\n<ul>\n<li aria-level=\"1\"><strong>Tobacco smoking:</strong> Associated with 90% of lung cancers.</li>\n<li aria-level=\"1\"><strong>Occupational</strong> and <strong>environmental</strong> <strong>exposure</strong> to carcinogens: Includes passive smoking, environmental air pollution, radon, asbestos, arsenic, chromium, nickel, beryllium, and silica.</li>\n<li aria-level=\"1\"><strong>Family history</strong> (genetic predisposition).</li>\n<li aria-level=\"1\">Other risk factors: Pulmonary scarring, previous radiation, pulmonary fibrosis, and chronic infections (e.g., tuberculosis, HIV).</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4405",
      "difficulty": "medium"
    },
    {
      "text": "Which of the factors would suggest a risk for a patient with TIA developing stroke in the future according to ABCD2 scoring?",
      "choices": [
        {
          "id": 1,
          "text": "Age < 60 years"
        },
        {
          "id": 2,
          "text": "SBP >130 mm Hg and DBP > 80 mm Hg"
        },
        {
          "id": 3,
          "text": "Duration of TIA  >5 mins"
        },
        {
          "id": 4,
          "text": "Diabetes"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>According to the <strong>ABCD2</strong> scoring system, which is commonly used to assess the short-term risk of stroke following a <strong>transient ischemic attack (TIA),</strong> <strong>diabetes</strong> would suggest a higher risk factor.</p>\n<p><strong>Age more than 60 years,</strong> <strong>SBP more than 140</strong> or <strong>DBP more than 90</strong> mmHg, and duration of TIA of <strong>10-59 minutes</strong> or <strong>more than 60 minutes</strong> are other criteria included in the ABCD2 scoring system.</p>\n<p>TIA is defined as episodes of stroke symptoms that last for only a brief period of time<strong> (&lt;24 hours).</strong> The ABCD2 scoring system is most frequently used to calculate the short-term risk of stroke after TIA.</p><hr><h3>Related Pearl: ABCD2 Score</h3><p>The risk of stroke <strong>following TIAs</strong> is determined by <strong>ABCD<sup>2</sup> score:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td><strong>A</strong>ge&nbsp;<span>&gt;</span> 60&nbsp;</td>\n<td>1</td>\n</tr>\n<tr>\n<td>S<strong>B</strong>P&gt;140 mmHg or D<strong>B</strong>P &gt;90 mmHg</td>\n<td>1</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>C</strong>linical symptoms:</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Unilateral weakness</li>\n</ul>\n</td>\n<td>2</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Speech disturbances without&nbsp;weakness</li>\n</ul>\n</td>\n<td>1</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>D</strong>uration:</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>&gt;60 minutes</li>\n</ul>\n</td>\n<td>2</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>10 - 59 minutes</li>\n</ul>\n</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetes</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>Total score</strong></td>\n<td><strong>Sum each score</strong></td>\n</tr>\n<tr>\n<td>ABCD2 Score Total</td>\n<td>3-months Rate of stroke (%)</td>\n</tr>\n<tr>\n<td>0</td>\n<td>0</td>\n</tr>\n<tr>\n<td>1</td>\n<td>2</td>\n</tr>\n<tr>\n<td>2</td>\n<td>3</td>\n</tr>\n<tr>\n<td>3</td>\n<td>3</td>\n</tr>\n<tr>\n<td>4</td>\n<td>8</td>\n</tr>\n<tr>\n<td>5</td>\n<td>12</td>\n</tr>\n<tr>\n<td>6</td>\n<td>17</td>\n</tr>\n<tr>\n<td>7</td>\n<td>22</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4390",
      "difficulty": "medium"
    },
    {
      "text": "The serum electrolyte values of a patient weighing 60kg are given below. Calculate the sodium deficit in the patient. \npH: 7.42, Na+: 120 mEq/L, serum K+: 4 mEq/L, serum Cl-: 90 mEq/L.",
      "choices": [
        {
          "id": 1,
          "text": "20 mEq"
        },
        {
          "id": 2,
          "text": "200 mEq"
        },
        {
          "id": 3,
          "text": "400 mEq"
        },
        {
          "id": 4,
          "text": "720 mEq"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The sodium deficit is calculated as<strong> (target sodium concentration-current sodium concentration) x 0.6 x Body weight</strong> (kg).</p>\n<p>Substituting the values, sodium deficit = (140-120) x 0.6 x 60 = <strong>720 mEq.</strong></p>\n<p>To calculate the<strong> sodium deficit</strong> in the patient, we first need to determine the <strong>target&nbsp;sodium concentration</strong> and compare it to the <strong>current sodium concentration.</strong></p>\n<p>The target sodium concentration can be calculated using the following formula:<br /><strong>Target Na concentration&nbsp; = (Lower limit of serum sodium concentration + upper limit of serum sodium concentration) / 2</strong></p>\n<p>In this case, we assume the lower limit for the serum sodium concentration is 135 mEq/L, and the upper limit is 145 mEq/L.</p>\n<p>Target Na concentration = (135 + 145) / 2=<strong> 140 mEq/L</strong></p>\n<p>Next, the current sodium deficit can be calculated using the following formula:<br /><strong>Sodium Deficit = (Target sodium concentration-current sodium concentration) x Total Body Water (TBW)&nbsp;</strong></p>\n<p>Total Body Water (TBW) = Weight (in kg) &times; 0.6 (assuming 60% of body weight is water); TBW = 60 &times; 0.6= <strong>36 liters</strong></p>\n<p><strong>Sodium Deficit</strong> = (140 - 120) x 36 = 20 x 36 = <strong>720 mEq</strong></p>\n<p>Therefore, the sodium deficit in the patient is 720 mEq.</p>\n<p><strong>Rapid sodium correction</strong> of 4&ndash;6 mEq/L should be achieved in the<strong> first 6 hours</strong> of therapy for patients with<strong> acute hyponatremia.</strong></p>\n<p>The rate of correction should be comparatively <strong>slow</strong> in <strong>chronic hyponatremia:</strong> <strong>&lt;6-8 mEq/L</strong> in the <strong>first 24 h</strong> and &lt;6 mEq/L each subsequent 24h, so as to avoid <strong>osmotic demyelination syndrome.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4385",
      "difficulty": "hard"
    },
    {
      "text": "In a patient with non-ST-elevation myocardial infarction (NSTEMI), all the following can be used for treatment except?",
      "choices": [
        {
          "id": 1,
          "text": "Aspirin"
        },
        {
          "id": 2,
          "text": "Clopidogrel"
        },
        {
          "id": 3,
          "text": "Streptokinase"
        },
        {
          "id": 4,
          "text": "Prasugrel"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Streptokinase</strong> is not used in the management of <strong>non-ST segment elevation MI</strong> (NSTEMI). It is a fibrin non-specific plasminogen activator used as a fibrinolytic agent in the treatment of ST-segment elevation MI (STEMI). <strong>Aspirin, clopidogrel, and prasugrel</strong> are antiplatelet drugs commonly used in the management of NSTEMI.</p>\n<p><strong>Fibrinolytic therapy</strong> is not indicated in patients with <strong>unstable angina</strong> or <strong>NSTEMI</strong>, unlike in STEMI. This is because <strong>STEMI</strong> is almost always caused by <strong>plaque rupture</strong> leading to the formation of an <strong>occluding thrombus</strong>, whereas, <strong>NSTEMI</strong> can be caused by a stable <strong>non-occluding plaque</strong> with some amount of lumen still patent. Fibrinolytic therapy may lead to the rupture of the stable plaque causing more damage.</p>\n<p><strong>Acute coronary syndrome</strong> is classified into 2 groups:</p>\n<ul>\n<li aria-level=\"1\">ST-segment Elevation Myocardial Infarction (STEMI)</li>\n<li aria-level=\"1\">NSTE-ACS</li>\n</ul>\n<p><strong>NSTE-ACS</strong> further includes:</p>\n<ul>\n<li aria-level=\"1\">NSTEMI (myocyte necrosis present and cardiac troponins elevated)</li>\n<li aria-level=\"1\">Unstable Angina (myocyte necrosis absent and cardiac troponins not elevated)</li>\n</ul>\n<p>The treatment of NSTEMI is as follows:</p>\n<ul>\n<li>Admission to a specialized cardiac unit</li>\n<li>Inhaled <strong>oxygen</strong></li>\n<li>Bed rest with <strong>continuous ECG monitoring</strong></li>\n<li>Monitoring cardiac biomarkers</li>\n<li>Morphine or opioid analgesics</li>\n<li><strong>Nitrates</strong></li>\n<li><strong>Beta-blockers</strong></li>\n<li>Antiplatelet drugs like <strong>aspirin</strong>,&nbsp;<strong>clopidogrel, prasugrel</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4377",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents with vertigo,  diplopia, hoarseness,  dysphagia, and left Horner’s syndrome associated with numbness of the left face and right side limbs. Which artery is affected in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Posterior inferior cerebellar artery"
        },
        {
          "id": 2,
          "text": "Superior cerebellar artery"
        },
        {
          "id": 3,
          "text": "Anterior inferior cerebellar artery"
        },
        {
          "id": 4,
          "text": "Basillar artery"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>These given features collectively indicate a diagnosis of <strong>Wallenberg or lateral medullary syndrome,</strong> which is typically caused by a lesion of the <strong>posterior inferior cerebellar artery.&nbsp;</strong></p>\n<p>The patient presents with hoarseness and dysphagia, suggesting the involvement of cranial nerves<strong> IX and X,</strong> which helps localize the lesion to the <strong>medulla</strong>. Additionally, the presence of vertigo and diplopia (involving the <strong>vestibular nerve</strong>), left-sided Horner's syndrome (involving the <strong>descending sympathetic tract</strong>), numbness on the left side of the face (involving the sensory tract of <strong>trigeminal nucleus</strong>), and numbness in the right side limbs (involving the <strong>lateral spinothalamic tract</strong>) further aids in localizing the lesion to the lateral part of the medulla.</p>\n<p>The absence of motor symptoms suggests that the pyramidal tracts in the medial aspect of the medulla are not involved, ruling out medial medullary syndrome.</p>\n<p>Wallenberg/lateral medullary syndrome&nbsp;affects:</p>\n<ul>\n<li aria-level=\"1\">Descending tract and nucleus of <strong>CN V-</strong> loss of pain and sensation over the ipsilateral half of the face.</li>\n<li aria-level=\"1\"><strong>Inferior cerebellar peduncle</strong> &ndash; ipsilateral ataxia&nbsp;</li>\n<li aria-level=\"1\"><strong>Lateral spinothalamic tract</strong> &ndash; loss of pain and temperature sensation over the contralateral half of the body.&nbsp;</li>\n<li aria-level=\"1\">CN<strong> IX and X</strong> - ipsilateral paralysis of palate, vocal cord, diminished gag reflex giving rise to dysphagia, dysarthria.</li>\n<li aria-level=\"1\">Vestibular nucleus - Nystagmus, diplopia, vertigo, nausea</li>\n<li aria-level=\"1\"><strong>Descending sympathetic tract</strong> &ndash; ipsilateral Horner&rsquo;s syndrome (miosis, ptosis, and anhidrosis).</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/58105eba00354e34b9271a088ec2e5f1x1280x1530.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Medullary syndromes and Weber syndrome</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Syndrome</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Vessel involved</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Clinical features</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Medial Medullary syndrome / Dejerine syndrome</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Vertebral artery/Anterior spinal artery</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p1\">C/L loss of conscious proprioception</li>\n<li class=\"p1\">C/L hemiplegia</li>\n<li class=\"p1\">I/L tongue paralysis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Lateral Medullary syndrome / Wallenberg syndrome</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Vertebral artery&gt;Posterior inferior cerebellar artery</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p1\">C/L loss of pain/temperature on the body</li>\n<li class=\"p1\">I/L loss of pain/temperature on face</li>\n<li class=\"p1\">Ataxia</li>\n<li class=\"p1\">Nystagmus</li>\n<li class=\"p1\">Vertigo</li>\n<li class=\"p1\">Horner's syndrome</li>\n<li class=\"p1\">dysphagia</li>\n<li class=\"p1\">Ipsilateral bulbar paralysis</li>\n<li class=\"p1\">Loss of gag reflex</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Weber's syndrome</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Posterior cerebral artery</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p1\">I/L Oculomotor nerve palsy - ptosis with fixed dilated pupil pointed down and out</li>\n<li class=\"p1\">C/L hemiplegia</li>\n<li class=\"p1\">C/L paralysis of the lower face</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>C/L- Contralateral</p>\n<p>I/L-Ipsilateral</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4369",
      "difficulty": "medium"
    },
    {
      "text": "Resistant hypertension is defined as?",
      "choices": [
        {
          "id": 1,
          "text": "BP >160/90 mmHg with one anti-hypertensive"
        },
        {
          "id": 2,
          "text": "BP >140/90 mmHg with one anti-hypertensive"
        },
        {
          "id": 3,
          "text": "BP >160/90 mmHg with three or more anti-hypertensives"
        },
        {
          "id": 4,
          "text": "BP >140/90 mmHg with three or more anti-hypertensives"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Resistant hypertension</strong> is defined as blood pressure being persistently <strong>&gt;140/90 mmHg</strong> despite taking <strong>three or more antihypertensive agents,</strong> including a <strong>diuretic</strong>.</p>\n<p>Resistant hypertension is more common in patients aged <strong>&gt;60 years</strong> than in younger patients.</p>\n<p>Resistant hypertension may be related to <strong>pseudohypertension</strong> (high office blood pressure and lower home blood pressure measurements), no<strong>n</strong>adherence to therapy, and <strong>secondary</strong> <strong>causes</strong> of hypertension including obesity, excessive alcohol intake, and primary aldosteronism.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4251",
      "difficulty": "medium"
    },
    {
      "text": "Components of the MELD (2016) score are all except?",
      "choices": [
        {
          "id": 1,
          "text": "Bilirubin"
        },
        {
          "id": 2,
          "text": "INR"
        },
        {
          "id": 3,
          "text": "Albumin"
        },
        {
          "id": 4,
          "text": "Creatinine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Albumin is not a component of the MELD (2016) score.</p>\n<p>The <strong>Model for End-Stage Liver Disease</strong> (MELD) is used as an indicator of short-term survival in patients with end-stage liver disease and to determine organ allocation priorities for liver transplantation. The components of the original MELD model were:</p>\n<ul>\n<li><strong>Serum creatinine</strong></li>\n<li><strong>Serum bilirubin</strong></li>\n<li><strong>INR </strong>(international normalized ratio)</li>\n</ul>\n<p><strong>In 2016</strong>, it was modified to incorporate serum <strong>sodium</strong> (the MELD-Na score).</p>\n<p>The latest MELD 3.0 scoring system has added two additional components:</p>\n<ul>\n<li><strong>Serum albumin</strong></li>\n<li><strong>Female gender</strong></li>\n</ul>\n<p>Patients with <strong>high scores</strong> have <strong>poor prognoses</strong> <strong>without intervention</strong> and should therefore be prioritized for transplantation if eligible.</p><hr><h3>Related Pearl: Revised Model for End-stage liver disease  (MELD) scoring system: MELD 3.0</h3><p>MELD 3.0 score has the following components (Mnemonic <strong>F BASIC</strong>)</p>\n<ul>\n<li>Female sex</li>\n<li>Bilirubin</li>\n<li>Albumin</li>\n<li>Serum sodium (mEq/L)</li>\n<li>INR (International Normalized ratio)</li>\n<li>Creatinine</li>\n</ul>\n<p><strong>Uses:</strong></p>\n<ul>\n<li>Predict short-term prognosis in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) insertion</li>\n<li>Assess and <strong>prioritize patients</strong> awaiting <strong>liver transplantation</strong></li>\n<li>Assess prognosis in cirrhosis</li>\n</ul>\n<p class=\"bulletIndent1\">&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4247",
      "difficulty": "medium"
    },
    {
      "text": "A woman with Grave's disease was taking antithyroid medication throughout her pregnancy. The baby was born with aplasia cutis congenita. Which drug could have caused this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Carbimazole"
        },
        {
          "id": 2,
          "text": "Levothyroxine"
        },
        {
          "id": 3,
          "text": "Methylthiouracil"
        },
        {
          "id": 4,
          "text": "Hydrouracil"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Carbimazole</strong> intake during the<strong> first trimester</strong> of pregnancy is associated with<strong> aplasia cutis congenita.</strong></p>\n<p><strong>Carbimazole</strong> and <strong>methimazole</strong> are associated with teratogenic effects such as:</p>\n<ul>\n<li aria-level=\"1\"><strong>Aplasia cutis congenita:</strong> Congenital absence of scalp hair and skin along with calvarial defects</li>\n<li aria-level=\"1\">Choanal atresia</li>\n<li aria-level=\"1\">Tracheoesophageal fistula</li>\n<li aria-level=\"1\">Fetal goiter</li>\n</ul>\n<p>The <strong>drug of choice</strong> for the treatment of hyperthyroidism during the <strong>first trimester</strong> of pregnancy is <strong>propylthiouracil</strong> (PTU). It is because it has lower teratogenic effects than carbimazole or methimazole.</p>\n<p>However, propylthiouracil use is limited to the first trimester due to the risk of <strong>hepatotoxicity</strong>. It is replaced with methimazole (or carbimazole) in the <strong>second</strong> and <strong>third</strong> <strong>trimesters</strong> of the pregnancy.</p>\n<p><strong>Radioiodine</strong> therapy is <strong>contraindicated</strong> during pregnancy and lactation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4185",
      "difficulty": "easy"
    },
    {
      "text": "In the given acid-base nomogram diagram, areas marked A and D indicate which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Chronic respiratory acidosis, acute metabolic alkalosis"
        },
        {
          "id": 2,
          "text": "Acute Metabolic alkalosis, acute respiratory acidosis"
        },
        {
          "id": 3,
          "text": "Acute respiratory acidosis, acute respiratory alkalosis"
        },
        {
          "id": 4,
          "text": "Acute respiratory acidosis, acute metabolic alkalosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given illustrated acid-base nomogram, the letters <strong>A</strong> and<strong> D</strong> indicate<strong> acute respiratory acidosis</strong> and <strong>acute respiratory alkalosis</strong>.</p>\n<p>An acid-base nomogram, also known as a <strong>Davenport diagram,</strong> is a graphical representation of acid-base balance to interpret arterial blood gas (ABG) results. It helps determine the primary acid-base disorder and identify compensatory mechanisms.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e5b3a554c29d42aab8be74cc471cb156x1280x1555.JPEG\" alt=\"Explanation Image\"><p>The <strong>y-axis</strong> of the acid-base nomogram represents the <strong>arterial bicarbonate (HCO3-) levels,</strong> and the <strong>x-axis</strong> represents the<strong> arterial pH</strong> values. The <strong>shaded</strong> areas are the <strong>range</strong> of values of the <strong>normal respiratory and metabolic compensations</strong> for primary acid-base disturbances.</p><hr><h3>Related Pearl: Acid-Base Balance - Normal Values</h3><table>\n<tbody>\n<tr>\n<td>Component</td>\n<td>Normal Range</td>\n<td>Optimal Value</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.35 - 7.45</td>\n<td>7.4</td>\n</tr>\n<tr>\n<td>HCO<sub>3</sub><sup>-</sup>&nbsp;</td>\n<td>22 - 28 mEq/L&nbsp;</td>\n<td>&nbsp;24 mEq/L</td>\n</tr>\n<tr>\n<td>pCO<sub>2</sub></td>\n<td>35 - 45 mmHg</td>\n<td>40 mmHg&nbsp;</td>\n</tr>\n<tr>\n<td>Anion gap</td>\n<td>6 - 12 mEq/L</td>\n<td>&lt;10 mEq/L</td>\n</tr>\n<tr>\n<td>O<sub>2</sub> saturation</td>\n<td colspan=\"2\">&gt; 95%</td>\n</tr>\n<tr>\n<td>pO<sub>2</sub></td>\n<td colspan=\"2\">75 - 100 mmHg&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Expected compensation in acid-base disorders</h3><table>\n<tbody>\n<tr>\n<td>Primary disorder</td>\n<td>Expected compensation</td>\n</tr>\n<tr>\n<td>Metabolic acidosis</td>\n<td>\n<p>Expected PaCO<sub>2</sub> = [1 .5 X HCO<sub>3</sub><sup>-</sup>] + 8 &plusmn; 2; or</p>\n<p>&darr; PaCO2 = 1.25 x &Delta;HCO3</p>\n</td>\n</tr>\n<tr>\n<td>Metabolic alkalosis</td>\n<td>Increase in PaCO<sub>2 </sub>= 0.75 x &Delta;HCO<sub>3</sub><sup>-</sup></td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Respiratory acidosis</p>\n</td>\n</tr>\n<tr>\n<td>Acute</td>\n<td>\n<p>Increase in HCO<sub>3</sub><sup>- </sup>= 0.1 x &Delta; PaCO<sub>2</sub></p>\n<p>&darr; pH = 0.008 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td>Chronic</td>\n<td>\n<p>Increase in HCO<sub>3</sub><sup>- </sup>= 0.4 x &Delta; PaCO<sub>2</sub></p>\n<p>&darr; pH = 0.003 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Respiratory alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute</p>\n</td>\n<td>\n<p>Decrease in HCO<sub>3</sub><sup>- </sup>= 0.2 x &Delta; PaCO<sub>2</sub></p>\n<p>&uarr; pH = 0.008 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic</p>\n</td>\n<td>\n<p>Decrease in HCO<sub>3</sub><sup>- </sup>= 0.4 x &Delta; PaCO<sub>2</sub></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/1642dd51e16b485aa9ff24c7a6d6ca59.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6729",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with the complaints of chest pain. Which among the following is the best investigation to diagnose MI within 2-4 hours?",
      "choices": [
        {
          "id": 1,
          "text": "LDH"
        },
        {
          "id": 2,
          "text": "CKMB"
        },
        {
          "id": 3,
          "text": "Troponin-T"
        },
        {
          "id": 4,
          "text": "BNP"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Measurement of troponin is the best investigation to diagnose MI within 2-4 hours.</p>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4ed64afdfd20483f9ce84324d54c018bx1280x1171.JPEG\" alt=\"Explanation Image\"><p><strong>Troponin T/I:</strong></p>\n<ul>\n<li><strong>Highly specific </strong>for MI</li>\n<li>Troponin I is more important than troponin T.</li>\n<li>Troponins will remain elevated longer than creatine kinase (CK), for up to 14 days.</li>\n<li>This makes troponins a superior marker for diagnosing MI in the recent past (late diagnosis).</li>\n<li><strong>Reinfarction: </strong>It is now clear that cardiac troponin (cTn) increases rapidly, even if it is from an abnormal baseline in patients with reinfarction.</li>\n<li>Sometimes <strong>cTn concentration</strong> is elevated, but stable or decreasing at the time of suspected reinfarction. In this case, the diagnosis of reinfarction requires a <strong>20% or greater</strong> increase in the cTn measurement</li>\n</ul>\n<p><strong>Creatine kinase (CK):</strong></p>\n<ul>\n<li><strong>Less sensitive </strong>and<strong> specific</strong> than troponins</li>\n<li>When cTn is available, CK-MB should not be used for the initial diagnosis of acute MI</li>\n</ul>\n<p><strong>Lactate dehydrogenase (LDH):</strong></p>\n<ul>\n<li>Normally, LDH2&gt;LDH1; but, in MI, LDH1&gt;LDH2. This is called <strong>flipping of the LDH ratio</strong>.</li>\n<li>Current recommendations suggest that LDH no longer has a role in the diagnosis of MI.</li>\n</ul>\n<p><strong>Myoglobin:</strong></p>\n<ul>\n<li aria-level=\"1\"><strong>Earliest enzyme</strong> to increase after MI.</li>\n<li aria-level=\"1\">Not specific to cardiac muscle and can be elevated to any form of injury to skeletal muscle.</li>\n</ul>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Heart-type fatty acid-binding protein (H-FABP), which mainly exists inside cardiomyocytes, has recently emerged as a potentially promising biomarker, which was found to be sensitive for the early diagnosis of acute myocardial infarction. H-FABP as an early marker and cTnI as a late marker would be the ideal combination to cover the complete diagnostic window for AMI&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:33563519,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:6989903},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;9&quot;:0,&quot;11&quot;:4,&quot;12&quot;:0,&quot;16&quot;:10,&quot;28&quot;:1}\"><strong>Heart-type fatty acid-binding protein</strong> (H-FABP), which mainly exists in cardiomyocytes, has recently emerged as a potential biomarker, which was found to be sensitive for the early diagnosis of acute myocardial infarction. H-FABP as an early marker and cTnI as a late marker would be the ideal combination to cover the complete diagnostic window for AMI</span></p><hr><h3>Related Pearl: Cardiac Biomarkers</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Time to initial elevation</strong></td>\n<td><strong>Mean time to peak elevation</strong></td>\n<td><strong>Time to return to normal range</strong></td>\n</tr>\n<tr>\n<td>Myoglobin</td>\n<td>1- 4 h</td>\n<td>12 h</td>\n<td>24 h</td>\n</tr>\n<tr>\n<td>CK-MB</td>\n<td>4-8 h</td>\n<td>24 h</td>\n<td>48-72 h</td>\n</tr>\n<tr>\n<td>cTnI</td>\n<td>3-12 h</td>\n<td>24 h</td>\n<td>7-10 d</td>\n</tr>\n<tr>\n<td>cTnT</td>\n<td>3-12 h</td>\n<td>12h &ndash; 2d</td>\n<td>7-10 d&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>CK-MB: Creatine kinase-MB; CTnI: Cardiac-specific troponin I; CTnT: Cardiac-specific troponin T&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/af5c41b3daaa4572985768e9c8081561x1280x1144.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6740",
      "difficulty": "medium"
    },
    {
      "text": "A patient comes with palpitation to ER. His Pulse-180/min and BP-70mm of Hg systolic. ECG shows narrow QRS complex tachycardia with regular heart rate. What is the next step in management?",
      "choices": [
        {
          "id": 1,
          "text": "DC Cardioversion"
        },
        {
          "id": 2,
          "text": "Adenosine"
        },
        {
          "id": 3,
          "text": "Valsalva Maneuver"
        },
        {
          "id": 4,
          "text": "Verapamil"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario of the patient presenting with <strong>palpitations</strong> and the electrocardiogram (ECG) showing<strong> narrow QRS complex tachycardia</strong> with <strong>regular heart rate</strong> suggests a <strong>paroxysmal supraventricular tachycardia.</strong> As the patient is <strong>hemodynamically unstable</strong> (SBP of 70 mmHg), the next step in management is <strong>DC (direct current) cardioversion.</strong></p>\n<p>PSVT is a narrow QRS complex tachycardia with sudden onset and termination. It mainly presents with dizziness and palpitations. Evaluation of these patients includes monitoring of vitals and ECG.</p>\n<p>The ECG below shows PSVT.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2fbcf5dbbd664b00b0670113380120dfx720x363.JPEG\" alt=\"Explanation Image\"><p>Management of PSVT is as follows:</p>\n<p>1) When the patient is <strong>hemodynamically stable:</strong></p>\n<ul>\n<li aria-level=\"1\"><strong>Carotid sinus massage</strong> is attempted. It is avoided if carotid bruit is present and if a prior history of stroke is present</li>\n<li aria-level=\"1\"><strong>Valsalva maneuver</strong> is done when the patient is cooperative</li>\n<li aria-level=\"1\">Intravenous<strong> adenosine</strong> is useful in most cases. It is usually given in a bolus dose of 6 mg (IV bolus over 2-3 seconds followed by a rapid flush with 20 mL NS followed by a dose of 12 mg if required. However, its usage is contraindicated in patients with prior cardiac transplantation as it can aggravate bronchospasm and atrial fibrillation.</li>\n<li aria-level=\"1\">Intravenous<strong> calcium channel blockers</strong> such as verapamil or diltiazem and beta-blockers are helpful but can cause hypotension.</li>\n<li aria-level=\"1\">If there is no termination of the PSVT, then the next step is <strong>IV ibutilide + AV nodal&ndash;blocking agent </strong>(or) <strong>IV procainamide + AV nodal&ndash;blocking agent</strong> (or)<strong> cardioversion.</strong></li>\n</ul>\n<p>2) When the patient is<strong> hemodynamically unstable,</strong> i.e. when the patient has hypotension (BP&lt;90/60) with unconsciousness or respiratory distress, QRS-synchronous <strong>DC cardioversion</strong> is done.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/74fdb0fbf87c4ba3af78ce55dd0c7864x530x614.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Supraventricular tachycardias</h3><p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with narrow QRS complex:</strong></p>\n<ul>\n<li><strong>Narrow QRS with regular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Sinus tachycardia</strong></td>\n<td>Normal P wave, normal ECG features except for the rate</td>\n</tr>\n<tr>\n<td><strong>Focal atrial tachycardia</strong></td>\n<td>A single type of abnormal p wave morphology is seen</td>\n</tr>\n<tr>\n<td><strong>Junctional tachycardia</strong></td>\n<td>No p waves. Heart rate is 100- 200/ min</td>\n</tr>\n<tr>\n<td><strong>AV nodal reentry tachycardia</strong></td>\n<td>No p waves. Pseudo R' waves may be seen. Heart rate is 150-250/ min</td>\n</tr>\n<tr>\n<td><strong>Atrioventricular reentry tachycardia</strong></td>\n<td>P wave always follows QRS. RP interval&lt; PR interval</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter</strong></td>\n<td>Sawtooth shaped flutter waves are seen</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Narrow QRS with irregular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;<strong>Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Atrial fibrillation</strong></td>\n<td>No distinct p waves seen</td>\n</tr>\n<tr>\n<td><strong>Multifocal atrial tachycardia</strong></td>\n<td>More than 3 different abnormal p wave morphologies are seen</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter/tachycardia with variable block</strong></td>\n<td>ECG features of heart block are seen.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with wide QRS complex:</strong></p>\n<ul>\n<li>Antidromic AVRT (atrioventricular reentry tachycardia)</li>\n<li>Supraventricular tachycardias with bundle branch block</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6767",
      "difficulty": "medium"
    },
    {
      "text": "High anion gap acidosis with low bicarbonate levels is seen in all the following conditions except:",
      "choices": [
        {
          "id": 1,
          "text": "Renal tubular acidosis"
        },
        {
          "id": 2,
          "text": "Diabetic ketoacidosis"
        },
        {
          "id": 3,
          "text": "Lactic acidosis"
        },
        {
          "id": 4,
          "text": "Salicylate poisoning"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Renal tubular acidosis</strong> causes <strong>normal anion gap</strong> metabolic acidosis, not high anion gap acidosis.&nbsp;</p>\n<p>Normally, in the serum, the total number of cations is equal to the total number of anions. But, a few of the <strong>anionic proteins (e.g., albumin), phosphates, sulfates, and organic anions</strong> are not measured and this is called an <strong>anion gap</strong>. It is the difference between measured cations and measured anions and is estimated as:</p>\n<p><strong>Plasma anion gap = [Na+] &minus;([Cl-]+[HCO3-])</strong></p>\n<p>The normal anion gap ranges between <strong>6-12 mEq/L.</strong></p><hr><h3>Related Pearl: Causes of Metabolic Acidosis</h3><table>\n<tbody>\n<tr>\n<td>High Anion-Gap Metabolic Acidosis (MUDPILES)</td>\n<td>Normal Anion-Gap Metabolic Acidosis (FUSED CAR)</td>\n</tr>\n<tr>\n<td><strong>M</strong>ethanol</td>\n<td><strong>F</strong>istula pancreatic</td>\n</tr>\n<tr>\n<td><strong>U</strong>remia (Renal failure - Acute or Chronic)</td>\n<td><strong>U</strong>reterosigmoidostomy</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetic ketoacidosis</td>\n<td><strong>S</strong>mall bowel fistula</td>\n</tr>\n<tr>\n<td><strong>P</strong>araldehyde</td>\n<td><strong>E</strong>xtra chloride (Hyperalimentation)</td>\n</tr>\n<tr>\n<td><strong>I</strong>ron tablets, INH</td>\n<td><strong>D</strong>iarrhea</td>\n</tr>\n<tr>\n<td><strong>L</strong>actic acidosis</td>\n<td><strong>C</strong>arbonic anhydrase inhibitor (acetazolamide)</td>\n</tr>\n<tr>\n<td><strong>E</strong>thylene glycol</td>\n<td><strong>A</strong>ddison's disease</td>\n</tr>\n<tr>\n<td><strong>S</strong>alicylates</td>\n<td><strong>R</strong>enal tubular acidosis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Acid-Base Balance - Normal Values</h3><table>\n<tbody>\n<tr>\n<td>Component</td>\n<td>Normal Range</td>\n<td>Optimal Value</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.35 - 7.45</td>\n<td>7.4</td>\n</tr>\n<tr>\n<td>HCO<sub>3</sub><sup>-</sup>&nbsp;</td>\n<td>22 - 28 mEq/L&nbsp;</td>\n<td>&nbsp;24 mEq/L</td>\n</tr>\n<tr>\n<td>pCO<sub>2</sub></td>\n<td>35 - 45 mmHg</td>\n<td>40 mmHg&nbsp;</td>\n</tr>\n<tr>\n<td>Anion gap</td>\n<td>6 - 12 mEq/L</td>\n<td>&lt;10 mEq/L</td>\n</tr>\n<tr>\n<td>O<sub>2</sub> saturation</td>\n<td colspan=\"2\">&gt; 95%</td>\n</tr>\n<tr>\n<td>pO<sub>2</sub></td>\n<td colspan=\"2\">75 - 100 mmHg&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6790",
      "difficulty": "medium"
    },
    {
      "text": "A patient comes to the hospital with chest pain for the last 3 hours. Vitals are stable. ECG revealed ST depression and T wave inversion in anterior chest leads. Which of the following would be the most appropriate line of management in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "PCI"
        },
        {
          "id": 2,
          "text": "Thrombolysis with alteplase"
        },
        {
          "id": 3,
          "text": "Prophylaxis for arrhythmia"
        },
        {
          "id": 4,
          "text": "Aspirin with heparin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Based on the given clinical scenario of a patient presenting with<strong> sudden onset of chest pain,</strong> with ECG findings of<strong> ST depression</strong> in the anterior chest leads and<strong> T wave inversion,</strong> the most likely diagnosis is a <strong>non-ST-segment elevation-acute coronary syndrome (NSTE-ACS).</strong>  The most appropriate line of management in this patient would be to administer<strong> aspirin with heparin.</strong></p>\n<p>Percutaneous coronary intervention is indicated after coronary angiography in high-risk patients.</p>\n<p>Fibrinolytic therapy is not indicated in patients with NSTE-ACS.</p>\n<p>Arrhythmia prophylaxis is generally not routinely recommended in all patients with NSTE-ACS.</p>\n<p><strong>Acute coronary syndrome</strong> is classified into 2 groups:</p>\n<ul>\n<li aria-level=\"1\">ST-segment Elevation Myocardial Infarction <strong>(STEMI)</strong></li>\n<li aria-level=\"1\"><strong>NSTE-ACS</strong></li>\n</ul>\n<p>NSTE-ACS further includes:</p>\n<ul>\n<li aria-level=\"1\"><strong>NSTEMI</strong> (myocyte necrosis present and cardiac troponins elevated)</li>\n<li aria-level=\"1\"><strong>Unstable Angina</strong> (myocyte necrosis absent and cardiac troponins not elevated)</li>\n</ul>\n<p>The diagnosis of NSTE-ACS is based on the following:</p>\n<p><strong>Severe chest discomfort</strong> with at least <strong>one of 3</strong> features:</p>\n<ul>\n<li>Occurring at rest or minimal exertion and lasting for more than 10 minutes</li>\n<li>Recent onset</li>\n<li>Crescendo pattern</li>\n</ul>\n<p><strong>ECG</strong> showing:</p>\n<ul>\n<li aria-level=\"1\"><strong>ST segment depression</strong></li>\n<li aria-level=\"1\"><strong>T wave inversion</strong></li>\n</ul>\n<p> </p>\n<p><strong>Elevated cardiac troponins</strong> in case of NSTEMI.</p>\n<p>Management of NSTE-ACS:</p>\n<p>To provide relief of pain and discomfort, initial treatment includes bed rest, <strong>nitrates</strong>, <strong>beta blockers,</strong> and inhaled <strong>oxygen</strong> (only if arterial O2 saturation &lt;90%).</p>\n<p><strong>Antithrombotic therapy</strong> consisting of antiplatelet and anticoagulant drugs:</p>\n<ul>\n<li><strong>Dual antiplatelet therapy</strong> (DAPT): Aspirin (162-325 mg) AND one ADP receptor inhibitor (Ticagrelor, clopidogrel or prasugrel)</li>\n<li><strong>Anticoagulation:</strong> Enoxaparin, unfractionated heparin, fondaparinux or bivalirudin</li>\n<li>An early invasive strategy including <strong>diagnostic coronary angiography</strong> (within 2–72 hours of presentation) followed by <strong>revascularization (</strong>percutaneous coronary intervention/ coronary artery bypass grafting) is indicated for stabilized patients who are at high risk of coronary events (Based on TIMI, GRACE or HEART score).</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6791",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is the most life-threatening manifestation of CKD?",
      "choices": [
        {
          "id": 1,
          "text": "Decreased GFR"
        },
        {
          "id": 2,
          "text": "Increased creatinine"
        },
        {
          "id": 3,
          "text": "Hyperkalemia"
        },
        {
          "id": 4,
          "text": "Proteinuria"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Of the given options, <strong>hyperkalemia</strong> is the <strong>most life-threatening</strong> complication of chronic kidney disease (CKD) as it can result in <strong>cardiac arrhythmias</strong> and <strong>sudden death.</strong></p>\n<p>CKD is staged based on&nbsp;<strong>declining</strong>&nbsp;glomerular filtration rate (<strong>GFR</strong>) and <strong>albuminuria</strong>. The various clinical manifestations occur due to loss of kidney function and <strong>accumulation</strong> of various uremic toxins (<strong>urea</strong>, <strong>creatinine</strong>, and other products of protein metabolism).</p>\n<p>Complications of declining kidney function include:</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<ul>\n<li>Volume overload</li>\n<li><strong>Hyperkalemia</strong></li>\n<li>Metabolic acidosis</li>\n<li>Hyperphosphatemia</li>\n<li>Mineral and bone disorders</li>\n<li>Hypertension</li>\n<li>Anemia</li>\n<li>Dyslipidemia</li>\n</ul>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6805",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with massive abdominal swelling. Paracentesis fluid was sent for lab analysis and results show serum protein to be 3g/dL and ascitic fluid protein to be 1g/dL. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Congestive heart failure"
        },
        {
          "id": 2,
          "text": "Early Budd Chiari syndrome"
        },
        {
          "id": 3,
          "text": "Late Budd Chiari syndrome"
        },
        {
          "id": 4,
          "text": "Tuberculosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The likely diagnosis in the given clinical scenario with <strong>serum-ascites albumin gradient (SAAG)</strong> <strong>&gt;1.1g/dL</strong> [calculated as serum albumin level - ascitic fluid albumin level, which in this case is 3-1=2g/dL] and <strong>ascitic fluid protein &lt;2.5 g/dL</strong> is<strong> late Budd Chiari syndrome.</strong></p>\n<p>Serum-ascites albumin gradient (SAAG) can be used to differentiate between ascites due to <strong>portal hypertension</strong> and <strong>non-portal hypertensive ascites.</strong> It represents the pressure within the hepatic sinusoids and correlates with the <strong>hepatic venous pressure gradient.</strong></p>\n<p>It is given by the formula:&nbsp;SAAG = Serum albumin level - Ascitic fluid albumin level</p>\n<p>Interpretation of SAAG:</p>\n<ul>\n<li aria-level=\"1\">SAAG <strong>&ge;1.1</strong> g/dL indicates that the ascites is due to increased pressure in the hepatic sinusoids. It reflects the presence of<strong> portal hypertension.</strong></li>\n<li aria-level=\"1\">SAAG <strong>&lt;1.1</strong> g/dL indicates that the ascites is not related to portal hypertension. It may be due to i<strong>nfection or malignancy.</strong></li>\n</ul>\n<p>In cases with high-SAAG (&ge;1.1), <strong>ascitic protein level analysis</strong> further helps in identifying the etiology:</p>\n<ul>\n<li aria-level=\"1\"><strong>&ge;2.5 g/dL</strong> indicates that the hepatic sinusoids are normal and are allowing the passage of protein into the ascites as in <strong>early Budd-Chiari syndrome.</strong></li>\n<li aria-level=\"1\"><strong>&lt;2.5 g/dL</strong> indicates that the hepatic sinusoids have been damaged and scarred and no longer allow passage of protein as in <strong>late Budd-Chiari syndrome</strong></li>\n</ul><hr><h3>Related Pearl: Serum Ascites Albumin Gradient  (SAAG)</h3><p>The serum ascites albumin gradient is calculated as follows:</p>\n<p>SAAG = Serum albumin - Ascitic fluid albumin</p>\n<p>It can be used to determine the cause of ascites following ascitic fluid analysis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/08ad7499e5e74b398f3c98a430c6af02x1200x1361.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6821",
      "difficulty": "medium"
    },
    {
      "text": "Iritis is seen in all except:",
      "choices": [
        {
          "id": 1,
          "text": "SLE"
        },
        {
          "id": 2,
          "text": "Behcet's disease"
        },
        {
          "id": 3,
          "text": "Ulcerative colitis"
        },
        {
          "id": 4,
          "text": "Rheumatoid arthritis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Iritis is seen in all the above conditions except rheumatoid arthritis.</p>\n<p><strong>Iritis</strong> or iridocyclitis is also known as <strong>anterior uveitis.&nbsp;</strong></p>\n<p>Anterior uveitis is seen in:</p>\n<ul>\n<li>Ankylosing spondylitis</li>\n<li>Juvenile rheumatoid arthritis</li>\n<li>Psoriasis</li>\n<li>Reactive arthritis</li>\n<li><strong>Systemic lupus erythematosus</strong></li>\n<li>Leprosy</li>\n</ul>\n<p><strong>Posterior uveitis&nbsp;</strong>is seen in:</p>\n<ul>\n<li>Vogt-Koyanagi Harada syndrome</li>\n<li>Diseases like toxoplasmosis, cysticercosis, coccidioidomycosis, toxocariasis, histoplasmosis</li>\n<li>Infections- Candida, Pneumocystis carinii, Cryptococcus, Aspergillus, and Cytomegalovirus</li>\n<li>Cat-scratch disease, Whipple&rsquo;s disease, and brucellosis</li>\n</ul>\n<p><strong>Both</strong> anterior and posterior uveitis is seen in:</p>\n<ul>\n<li>Sarcoidosis</li>\n<li>Behcet's disease</li>\n<li>Inflammatory bowel disease</li>\n<li>Herpes infections, Syphilis, Lyme disease, TB, onchocerciasis</li>\n</ul>\n<p><strong>Intermediate uveitis/pars planitis</strong>&nbsp;is seen in multiple sclerosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6828",
      "difficulty": "medium"
    },
    {
      "text": "A 13-year-old boy collapsed while playing football. ECG showed V5, V6 inversion and prominent inverted T-waves. 2D echocardiography showed systolic anterior motion of the mitral valve leaflet. Which of the following features will be seen on clinical examination and which of the following are true regarding the management?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Clinical findings</strong></td>\n<td> <strong>Management</strong></td>\n</tr>\n<tr>\n<td>a. Pulsus bisferiens</td>\n<td>1. Beta-blockers are given</td>\n</tr>\n<tr>\n<td>b. Pulsus alternans</td>\n<td>2. Beta-blockers are contraindicated</td>\n</tr>\n<tr>\n<td>c. Ejection systolic murmur</td>\n<td>3. ICD is indicated</td>\n</tr>\n<tr>\n<td>d. Murmur increases on standing</td>\n<td>4. ICD is contraindicated</td>\n</tr>\n<tr>\n<td>e. Murmur decreases on standing</td>\n<td> </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 & 3, a, c, d"
        },
        {
          "id": 2,
          "text": "2 & 4, b,  c,  e"
        },
        {
          "id": 3,
          "text": "1 & 3, a, d"
        },
        {
          "id": 4,
          "text": "2 & 4, b, e"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario of a <strong>young</strong> patient with a history of <strong>sudden collapse</strong> following <strong>physical activity</strong> along with ECG findings of <strong>V5, V6 inversion,</strong> and <strong>prominent inverted T-waves,</strong> and 2D echocardiography showing the <strong>systolic anterior motion</strong> of the <strong>mitral</strong> valve leaflet point toward a diagnosis of <strong>hypertrophic obstructive cardiomyopathy (HCM).</strong></p>\n<p>In HCM, clinical examination may reveal <strong>pulsus bisferiens</strong> and an<strong> ejection systolic murmur</strong> that increases on <strong>standing</strong>.</p>\n<p>Beta-blockers and implantable cardioverter-defibrillators (ICD) are used in the management.</p>\n<p>HCM is a<strong> leading cause of sudden death in young.</strong> It is inherited in an <strong>autosomal dominant</strong> pattern with variable penetrance. HCM is characterized by the <strong>thickening</strong> of the septal myocardium below the aortic valve leading to <strong>obstruction</strong> of the<strong> left ventricular outflow tract.</strong></p>\n<p><strong>Symptoms:</strong></p>\n<ul>\n<li>Exertional dyspnea</li>\n<li>Syncope</li>\n<li>Angina, palpitations, cardiac arrhythmias</li>\n<li><strong>Sudden cardiac death </strong>(particularly during or after intense physical activity)</li>\n</ul>\n<p> </p>\n<p> </p>\n<p><strong>Examination:</strong></p>\n<ul>\n<li aria-level=\"1\"><strong>Systolic ejection murmur</strong> best heard at the <strong>apex</strong> or lower left sternal border</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>Parameters </td>\n<td> Murmur intensity increased</td>\n<td>Murmur intensity decreased</td>\n</tr>\n<tr>\n<td>\n<p>Preload </p>\n<p> </p>\n</td>\n<td>\n<p>Valsalva</p>\n<p>Standing</p>\n<p>(↓preload = ↑obstruction)</p>\n</td>\n<td>\n<p>Squatting  </p>\n<p>Passive leg raising</p>\n<p>(↑preload = ↓obstruction)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Force of contraction</p>\n</td>\n<td>\n<p>Exercise</p>\n<p>(↑force = ↑obstruction)</p>\n</td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Afterload</p>\n<p> </p>\n</td>\n<td>\n<p>Vasodilators </p>\n<p>(↓afterload = ↑obstruction)</p>\n</td>\n<td>\n<p>Isotonic handgrip</p>\n<p>Squatting</p>\n<p>(↑afterload = ↓obstruction)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li aria-level=\"1\">Holosystolic murmur from mitral regurgitation</li>\n<li aria-level=\"1\">Sustained apex beat</li>\n<li aria-level=\"1\"><strong>S4</strong> gallop</li>\n<li aria-level=\"1\">Paradoxical split of S2 </li>\n<li aria-level=\"1\"><strong>Pulsus bisferiens</strong>: LV outflow obstruction causes a sudden quick rise of the pulse followed by a slower longer rise.</li>\n</ul>\n<p>ECG findings:</p>\n<p> </p>\n<ul>\n<li><strong>Left axis deviation</strong></li>\n<li>P wave abnormalities </li>\n<li>Prominent abnormal Q waves</li>\n<li>Deeply inverted T waves </li>\n</ul>\n<p>Echocardiography findings:</p>\n<p> </p>\n<ul>\n<li aria-level=\"1\"><strong>LV wall thickness ≥15 mm</strong></li>\n<li aria-level=\"1\"><strong>Systolic anterior motion</strong> of the mitral valve leaflet</li>\n<li aria-level=\"1\">Mitral regurgitation</li>\n</ul>\n<p> </p>\n<p>Treatment: </p>\n<ul>\n<li aria-level=\"1\"><strong>Beta-blockers</strong> and <strong>calcium channel blockers</strong> are the first-line treatment </li>\n<li aria-level=\"1\"><strong>Implantable cardioverter-defibrillator (ICD)</strong> - indicated when the history of cardiac arrest or sustained ventricular tachycardia is present</li>\n</ul><hr><h3>Related Pearl: Dynamic auscultation of murmurs</h3><table>\n<tbody>\n<tr>\n<td><strong>Bedside Manoeuvre</strong></td>\n<td><strong>Effect</strong></td>\n</tr>\n<tr>\n<td>\n<p>Inspiration</p>\n<p>(&uarr;venous return to right atrium)</p>\n</td>\n<td>\n<ul>\n<li>&uarr; intensity of right-sided sounds</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Handgrip</p>\n<p>(&uarr;afterload )</p>\n</td>\n<td>\n<ul>\n<li>&uarr; intensity of MR, AR, and VSD murmurs</li>\n<li>&darr; hypertrophic cardiomyopathy and AS murmurs</li>\n<li>MVP: delayed onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Valsalva-Phase II, standing up</p>\n<p>(&darr; preload)</p>\n</td>\n<td>\n<ul>\n<li>&darr; intensity of most murmurs (including AS)</li>\n<li>&uarr;&nbsp;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>MVP: earlier onset of click /murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rapid squatting</p>\n<p>(&uarr;venous return,&uarr;preload,<br />&uarr; afterload)</p>\n</td>\n<td>\n<ul>\n<li>&darr;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>&uarr;&nbsp;intensity of AS, MR, and VSD murmurs</li>\n<li>MVP: later onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6952",
      "difficulty": "medium"
    },
    {
      "text": "You are posted as an intern in casualty. An elderly 60-year-old man is brought to you with complaints of chest pain. He has tested positive for COVID. Which of the following features will prompt you to get this patient admitted to dedicated COVID Health Centre?<div class='question-desc-html'><p>A. Respiratory rate of 25/min<br />B. SpO2 93%<br />C. Multiple comorbidities<br />D. Chest pain<br />E. Age</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "A & B only"
        },
        {
          "id": 2,
          "text": "A, B, C, & E only"
        },
        {
          "id": 3,
          "text": "A, B & C only"
        },
        {
          "id": 4,
          "text": "A, B, C, D & E"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>A, B, C &amp; E</strong> are clinical criteria of admission under COVID-19 ward.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/43d094ce4619426698ff0444460bf1f9x1280x4371.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6953",
      "difficulty": "medium"
    },
    {
      "text": "Correct sequence after p wave:\nA- 'a' wave\nB- 1st heart sound\nC- Rapid filling of ventricles\nD- 't' wave",
      "choices": [
        {
          "id": 1,
          "text": "ABCD"
        },
        {
          "id": 2,
          "text": "ABDC"
        },
        {
          "id": 3,
          "text": "CABD"
        },
        {
          "id": 4,
          "text": "ACBD"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct sequence is <strong>ABDC</strong>.</p>\n<p>A - '<strong>a' wave</strong>: The 'a' wave in the JVP waveform corresponds to <strong>atrial contraction</strong> and<strong> occurs just after the P wave </strong>on the ECG (which corresponds to atrial depolarization)&nbsp;and just before the first heart sound.</p>\n<p>B- <strong>1st heart sound</strong>: The <strong>closure of the mitral and tricuspid valves</strong> at the beginning of <strong>ventricular systole</strong> produces the 1st heart sound (S1) as the change in pressure across the AV valves causes them to close. This sound occurs soon after the QRS complex on the ECG waveform representing <strong>ventricular depolarization</strong>.</p>\n<p>The <strong>x-descent</strong> of the JVP waveform is associated with the <strong>ventricular systole.</strong> The <strong>c-wave</strong> occurs due to the bulging of the <strong>tricuspid</strong> valve into the <strong>atrium</strong> until the <strong>semilunar valves open.</strong></p>\n<p>D - <strong>'T' wave</strong>: Following ventricular depolarization, the <strong>ventricles</strong> start to <strong>repolarize</strong> represented by the 'T' wave on &nbsp;ECG. The <strong>2nd heart sound</strong> (S2) occurs due to the <strong>closure of the semilunar valves.</strong></p>\n<p>C- <strong>Rapid filling of ventricles</strong>: Ventricular repolarization triggers the <strong>ventricles</strong> to enter <strong>diastole</strong>. During early diastole, there is a phase of <strong>rapid filling</strong> of the ventricles. This occurs as the atrial pressure exceeds the ventricular pressure, allowing blood to passively flow from the atria to the ventricles.</p>\n<p>The <strong>3rd heart sound</strong> (S3) may be heard here. This event is associated with the <strong>v-wave </strong>and the<strong> y-descent </strong>on the JVP waveform as the ventricle relaxes further.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4dc1acd358c34e4fa932bc171e0f44edx1279x1280.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: JVP waveform and the abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/18bbe4a977c84587903e8637a0d9303cx1280x1005.JPEG\" alt=\"Pearl Image\"><p>1) The <strong>a-wave</strong> corresponds to <strong>atrial contraction</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prominent a-waves</strong></td>\n<td>Pulmonary hypertension, right atrial thrombus/ mass, and tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Cannon a-waves</strong></td>\n<td>\n<p>Complete AV block, ventricular tachycardia, and premature atrial/ junctional/ ventricular beats</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent a-waves</strong></td>\n<td>Atrial fibrillation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>2) The <strong>c-wave</strong> corresponds to the <strong>bulging of tricuspid valve</strong> into right atrium during ventricular contraction.</p>\n<p>&nbsp;</p>\n<p>3) The <strong>x-descent</strong> corresponds to <strong>atrial relaxation</strong> during atrial diastole.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Absent x-descent</strong></td>\n<td>Severe tricuspid regurgitation</td>\n</tr>\n<tr>\n<td><strong>Rapid x-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>4) The <strong>v-wave</strong> corresponds to the <strong>venous filling</strong> of right atrium.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Dominant v-waves</strong></td>\n<td>Tricuspid regurgitation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>5) The <strong>y-descent</strong> corresponds to the&nbsp;<strong>passive emptying of the right atrium</strong> into right ventricle.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prolonged y-descent</strong></td>\n<td>Tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Rapid y-descent</strong></td>\n<td>\n<p>Constrictive pericarditis and isolated severe tricuspid regurgitation</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent y-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Normal ECG waves and intervals</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>ECG wave/interval</strong></p>\n</td>\n<td>\n<p><strong>Physiological correlates</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>P wave</p>\n</td>\n<td>\n<p>Atrial depolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>QRS complex (up to 0.10s)</p>\n</td>\n<td>\n<p>Ventricular depolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T wave</p>\n</td>\n<td>\n<p>Ventricular repolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>U wave</p>\n</td>\n<td>\n<p>Repolarization of ventricular myocytes with long action potential</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PR interval&nbsp; (0.12-0.2s)&nbsp;</p>\n</td>\n<td>\n<p>Atrial depolarization and conduction through AV node</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>QT interval&nbsp; (up to 0.43s)</p>\n</td>\n<td>\n<p>Ventricular depolarization and Ventricular repolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ST interval (Average 0.32s)</p>\n<p>(QT minus QRS)</p>\n</td>\n<td>\n<p>Plateau portion of ventricular action potential+ Ventricular repolarisation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ST segment</p>\n</td>\n<td>\n<p>Plateau portion of ventricular action potential</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/70e10acc7b9f4c249713071ae9311e21x1280x1789.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6954",
      "difficulty": "medium"
    },
    {
      "text": "A 23-year-old medical student diagnosed with dengue developed epistaxis that resolved spontaneously. He has been afebrile for the last 24 hours, and his platelet count is 14,000/μL. His BP is 110/70 mmHg and there is a 28% rise in hematocrit. What should be the management?<div class='question-desc-html'><ol>\n<li>Give 4 units of platelets</li>\n<li>Give plenty of oral fluids</li>\n<li>Give IV fluids</li>\n<li>Keep under observation</li>\n<li>Discharge the patient&nbsp;</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 2"
        },
        {
          "id": 2,
          "text": "1, 2, and 4"
        },
        {
          "id": 3,
          "text": "2, 3, and 4"
        },
        {
          "id": 4,
          "text": "2 and 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical picture of a student diagnosed with <strong>dengue</strong> with history of an afebrile period, epistaxis, reduced platelet count and elevated hematocrit strongly suggests <strong>dengue hemorrhagic fever.</strong></p>\n<p>He should be kept under <strong>observation</strong> and given adequate<strong> oral and intravenous fluids</strong> <strong>(Statements 2,3 and 4).</strong>&nbsp;&nbsp;</p>\n<p><strong>Clinical criterion</strong> for dengue hemorrhagic fever is:</p>\n<ul>\n<li>Acute onset fever lasting 2-7 days.</li>\n<li>Hemorrhagic manifestations: positive tourniquet test, petechiae, ecchymoses, purpura, or <strong>bleeding from the mucosa,</strong> gastrointestinal tract, injection sites, or other locations.</li>\n<li>Platelet count <strong>&le; 100,000 cells/mm.</strong></li>\n<li>Objective evidence of plasma leakage: <strong>rising hematocrit</strong>/ haemoconcentration of &ge;20% from baseline or signs of plasma leakage (e.g., pleural effusion, ascites, hypoproteinemia/ albuminemia).</li>\n</ul>\n<p><strong>Severe</strong> dengue symptoms often come after the fever has <strong>subsided</strong>, when the capillary permeability may increase along with <strong>rising hematocrit</strong> levels. Progressive leukopenia, followed by a rapid decrease in platelet count, often precedes plasma leakage.</p>\n<p>The main pathology in dengue is plasma leakage, resulting in intravascular volume depletion and thereby shock. So, supportive management with <strong>oral or intravenous rehydration</strong> is the mainstay of treatment. If the patient is febrile, <strong>paracetamol</strong> is administered to maintain body temperature. NSAIDs should be avoided since they can cause gastritis, platelet dysfunction, and severe bleeding.</p>\n<p>Patients should be kept under <strong>observation</strong> and vital parameters like blood pressure, urine output, platelet count, and rise or fall in hematocrit should be monitored.</p>\n<p>Indications for <strong>platelet transfusion</strong> in dengue:</p>\n<p>&nbsp;</p>\n<ul>\n<li>Platelet count &lt; 10,000/cu.mm.</li>\n<li>Prolonged shock with coagulopathy and abnormal coagulogram</li>\n<li>Systemic massive bleeding</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6955",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following are true regarding KF ring?<div class='question-desc-html'><ol>\n<li>Seen in all patients with neurological involvement</li>\n<li>Is seen only for Wilson's disease</li>\n<li>Resolves with desferrioxamine</li>\n<li>Seen in all patients with hepatic involvement</li>\n<li>Seen in superior and inferior pole of Descemet's membrane</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2 and 5 only"
        },
        {
          "id": 2,
          "text": "1 and 5 only"
        },
        {
          "id": 3,
          "text": "1, 2, 3, 4 and 5"
        },
        {
          "id": 4,
          "text": "2, 3, 4 and 5 only"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Among the given options only <strong>statements 1 and 5 are true. </strong></p>\n<p><strong>Kayser-Fleischer (KF) rings</strong> are seen in almost all patients of <strong>Wilson's disease</strong> with neurological involvement. It initially appears as a <strong>crescent</strong> in the superior pole of <strong>Descemet's membrane</strong> and gradually extends inferiorly, eventually becoming <strong>circumferential</strong> in shape.</p>\n<p>KF rings occur due to <strong>copper</strong> deposition in the descemet's membrane. It is golden-brown to greenish-brown in color and can be best seen by <strong>slit-lamp</strong> examination.</p>\n<p>The image below shows a KF ring :&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/af5e1b00249b45648917b1cc46d266bfx720x632.PNG\" alt=\"Explanation Image\"><p>While it is a characteristic sign of Wilson&rsquo;s disease (<strong>statement 2</strong>), it can also be seen in:&nbsp;</p>\n<ul>\n<li>Primary biliary cholangitis</li>\n<li>Primary sclerosing cholangitis</li>\n<li>Cholestasis</li>\n</ul>\n<p>KF rings are present in almost <strong>95% </strong>of patients of Wilson's disease with neurological/psychiatric symptoms compared to around 65% of those with hepatic presentations<strong> (statement 4).</strong></p>\n<p>They <strong>disappear</strong> on treatment with <strong>copper-chelating agents</strong> like <strong>d-penicillamine </strong>(while desferrioxamine is an iron chelating agent) and <strong>reappear</strong> with disease progression<strong> (statement 3).</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6956",
      "difficulty": "medium"
    }
  ]
}